« Zurück
Startseite /
Anti-Human APRIL (Extracellular Domain-2) - 0.1 mg

Anti-Human APRIL (Extracellular Domain-2) - 0.1 mg

ArtNr	LEIN-A155-0.1mg
Hersteller	Leinco Technologies
Menge	0.1 mg
Quantity options	0.1 mg 20 ug
Kategorie	Antibodies Immunohistochemistry Western Blot Primary Antibodies
Typ	Antibody Primary
Applikationen	WB, IHC
Specific against	Human (Homo sapiens)
Host	Rabbit
Citations	1. Sarah G. Hymowitz et al. (2004) J Mol Biol. 343: 283 2. (1998) Jürg Tschopp 3. Ruggero De Maria et al. (2004) Blood 104: 3169
NCBI	8741
ECLASS 10.1	32160702
ECLASS 11.0	32160702
UNSPSC	12352203
Versandbedingung	Raumtemperatur
Lieferbar
Manufacturer - Applications	IHC FFPE, WB
Manufacturer - Category	Polyclonal Antibodies>Growth Factors & Cytokines
Manufacturer - Targets	A Proliferating-Inducing Ligand
Country of Origin	USA
Shipping Temperature	Next Day Ambient
Storage Conditions	This polyclonal antibody is stable for at least one week when stored at 2-8°C. For long term storage, aliquot in working volumes without diluting and store at –20°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles.
Product Description	A proliferation-inducing ligand (APRIL) is a TNF-like cytokine that stimulates tumor cell growth.1 It is of low abundance in normal tissues.2 APRIL acts as a proliferative factor in megakaryocytopoiesis, a developmental hematopoietic process responsible for progenitor cell differentiation to megakaryoblasts and megakaryocytes, leading to platelet formation.3 APRIL may be implicated in the regulation of tumor cell growth.2
Background	A proliferation-inducing ligand (APRIL) is a TNF-like cytokine that stimulates tumor cell growth.¹ It is of low abundance in normal tissues.² APRIL acts as a proliferative factor in megakaryocytopoiesis, a developmental hematopoietic process responsible for progenitor cell differentiation to megakaryoblasts and megakaryocytes, leading to platelet formation.³ APRIL may be implicated in the regulation of tumor cell growth.²
PubMed	A Proliferating-Inducing Ligand
Manufacturer - Specificity	Rabbit Anti-Human APRIL recognizes an epitope in the extracellular domain of Human and Mouse APRIL. This polyclonal antibody was purified using affinity chromatography.
RRID	AB_2828052
Concentration	0.5 mg/ml
Formulation	This polyclonal antibody is formulated in phosphate buffered saline (PBS) pH 7.4 containing 0.02% sodium azide as a preservative.
Immunogen	PN:A186
Additional Information	Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.
Keywords	Polyclonal Antibody, A Proliferating-Inducing Ligand, CD256, TNFSF13, TALL2, TRDL1, APRIL, Human, Anti-Human APRIL (Extracellular Domain-2)

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Arbeitsanleitung (Data Sheet) anfordern

Produkt-Datenblatt anfordern

LEIN-A155-0.1mg-safety-datasheet.pdf